Featured Post

Latest Gold News

Weak dollar, equities supporting gold Trump remains unimpressed with NAFTA   Business cycle winding down says Wall Street banks Klon...

Thursday, November 17, 2011

Akorn (AKRX) (VRUS) (WERN) (WPI) (AAT) (AEO) Ratings Reiterated

Akorn, Inc. (NASDAQ: AKRX), Pharmasset (NASDAQ: VRUS), Werner Enterprises, Inc. (NASDAQ: WERN), Watson Pharmaceuticals Incorporated (NYSE: WPI), American Assets Trust (NYSE: AAT) and American Eagle (NYSE: AEO) had ratings on them reiterated by analysts.

Piper Jaffray (NYSE:PJC) reiterated its "Overweight" rating on Akorn, Inc. (AKRX). They have a price target of $12.00 on the company.

Piper Jaffray reiterated its "Overweight" rating on Pharmasset (VRUS). They have a price target of $90.00 on the company.

Citigroup (NYSE:C) reiterated its "Buy" rating on Werner Enterprises, Inc. (WERN). They have a price target of $25.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Overweight" rating on Watson Pharmaceuticals Incorporated (WPI).

Morgan Stanley (NYSE:MS) reiterated its "Overweight" rating on American Assets Trust (AAT).

Goldman Sachs (NYSE:GS) reiterated its "Buy" rating on American Eagle (AEO).

No comments: